Co-occurring genomic alterations in non-small-cell lung cancer
By A Mystery Man Writer
Description
Dissecting the clinicopathologic, genomic, and immunophenotypic
Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting, BMC Cancer
Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes
Frontiers Concurrent Genetic Alterations and Other Biomarkers
TERT Mutations in Non–Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications - Liu Yang, Meng Wang, Na Li, Lu-Da Yan, Wen Zhou, Zhi-Qiong Yu, Xiao-Chun Peng, Jun Cai, Yong-Hua Yang, 2023
A high number of co-occurring genomic alterations detected by NGS
PDF) Mutational Landscape and Expression of PD-L1 in Patients with
Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes
Co-occurring genomic alterations in non-small-cell lung cancer
Comprehensive genomic profile of Chinese lung cancer patients and
Immunogenomic profiling of lung adenocarcinoma reveals high-grade growth patterns are associated with an immunogenic tumor microenvironment
from
per adult (price varies by group size)